Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Anturane (sulfinpyrazone USP), Novartis NDA 11-556/S-053 SULFINPYRAZONE Capsule; 200MG SULFINPYRAZONE Barr 087770 SULFINPYRAZONE Capsule; 200MG SULFINPYRAZONE Ivax 011556 SULFINPYRAZONE Capsule; 200MG ANTURANE NOVARTIS 088934 SULFINPYRAZONE Capsule; 200MG SULFINPYRAZONE Par 087665 SULFINPYRAZONE Tablet; 100MG SULFINPYRAZONE Barr 011556 SULFINPYRAZONE Tablet; 100MG ANTURANE NOVARTIS 088933 SULFINPYRAZONE Tablet; 100MG SULFINPYRAZONE Par ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com